These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 235090

  • 1. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH, Anderson GH, Freiberg JM, Dalakos TG.
    N Engl J Med; 1975 Mar 27; 292(13):657-62. PubMed ID: 235090
    [Abstract] [Full Text] [Related]

  • 2. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH, Dalakos TG, Anderson GH.
    Prog Biochem Pharmacol; 1976 Mar 27; 12():214-26. PubMed ID: 1019165
    [Abstract] [Full Text] [Related]

  • 3. Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113).
    Streeten DH, Freiberg JM, Anderson GH, Dalakos TG.
    Circ Res; 1975 Jun 27; 36(6 Suppl 1):125-32. PubMed ID: 1132074
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977 Jun 27; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
    McAfee JG, Thomas FD, Grossman Z, Streeten DH, Dailey E, Gagne G.
    J Nucl Med; 1977 Jul 27; 18(7):669-75. PubMed ID: 874145
    [Abstract] [Full Text] [Related]

  • 11. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug 27; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 12. Clinical experience with saralasin infusion in hypertensive patients.
    Tegtmeyer CJ, Latour EA, Vaughan ED, Ayers CR, Carey RM, Wellons HA.
    Invest Radiol; 1977 Aug 27; 12(6):496-504. PubMed ID: 591250
    [Abstract] [Full Text] [Related]

  • 13. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP, Rosenthal J, Wagner H, Franz HE.
    Proc Eur Dial Transplant Assoc; 1978 Aug 27; 15():412-7. PubMed ID: 740674
    [Abstract] [Full Text] [Related]

  • 14. Editorial: Angiotensin blockade: new pharmacologic tools for understanding and treating hypertension.
    Laragh JH.
    N Engl J Med; 1975 Mar 27; 292(13):695-6. PubMed ID: 235091
    [No Abstract] [Full Text] [Related]

  • 15. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G, Helber A, Meurer KA, Hummerich W, Wambach G, Kaufmann W.
    Dtsch Med Wochenschr; 1979 Mar 23; 104(12):432-7. PubMed ID: 436589
    [Abstract] [Full Text] [Related]

  • 16. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
    Romero JC, Holmes DR, Strong CG.
    Circ Res; 1977 May 23; 40(5 Suppl 1):I17-23. PubMed ID: 870227
    [Abstract] [Full Text] [Related]

  • 17. Outpatient experience with saralasin.
    Streeten DH, Anderson GH.
    Kidney Int Suppl; 1979 Mar 23; (9):S44-52. PubMed ID: 289863
    [No Abstract] [Full Text] [Related]

  • 18. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA, Mitchell HC.
    N Engl J Med; 1975 Jun 05; 292(23):1214-7. PubMed ID: 236513
    [Abstract] [Full Text] [Related]

  • 19. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Jun 05; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 20. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R.
    J Lab Clin Med; 1978 Mar 05; 91(3):473-9. PubMed ID: 627750
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.